Auberna SA (AEB 25%)

In November 2017, Affinity Energy and Health entered into a Heads of Agreement with Auberna SA (trading as United Biogenics “BioU”) to acquire a direct 25% equity interest in Auberna.

The acquisition provides AEB with direct equity in a globally significant, vertically integrated cannabis business. It also delivers ongoing exposure to leading R&D activities, including the development of proprietary methodologies to increase yields across multiple cannabinoid strains.